Beta thalassemia is an inherited blood disorder that affects the body's ability to produce healthy hemoglobin. Advances in medical science have significantly improved treatment options, helping patients manage symptoms and maintain a better quality of life. Modern approaches include regular blood transfusions.
Beta thalassemia is a genetic blood disorder that reduces the production of hemoglobin, a protein responsible for carrying oxygen throughout the body. Depending on the severity of the condition, individuals may require ongoing medical care to manage anemia and related complications. Modern treatment approaches have improved patient outcomes and increased life expectancy through better disease management and advanced therapeutic options.